HEALTHCAP VII ADVISOR AB
HEALTHCAP VII ADVISOR AB is a Seed, Series A, Series B and Series C+ fund in Europe, Nordics and Global writing $1M–$5M checks into Healthcare, life-sciences, oncology, rare-diseases, genetic-disorders, precision-medicine and pharma.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, life-sciences, oncology, rare-diseases, genetic-disorders, precision-medicine, pharma
- Check size
- $1M–$5M
- Invests in
- Europe, Nordics, Global
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 1996
- Assets under management
- EUR 1 billion
Thesis
HealthCap VII Advisor AB, part of the HealthCap umbrella, is a venture capital firm founded in 1996 and headquartered in Stockholm, Sweden, with an office in Lausanne, Switzerland. It specializes in the life sciences sector, with a core investment thesis focused on companies developing breakthrough therapies for diseases with high unmet medical needs, particularly rare diseases, oncology, and genetic disorders, emphasizing precision medicine. HealthCap invests across seed to growth equity stages (Series A, B, etc.). The broader HealthCap entity has raised over EUR 1.2 billion in committed capital across nine funds and reported EUR 1 billion in AUM as of 2023. HealthCap VII LP had $160.4 million in AUM in 2015. The firm's geographic scope is primarily Europe, including the Nordics, but also extends globally. HealthCap often acts as a lead investor. Typical check sizes for Seed stage investments are $1.0M – $5.0M. The firm has financed over 130 companies, with more than 45 IPOs and numerous acquisitions.
Common questions
Does HEALTHCAP VII ADVISOR AB invest at the Seed stage?
Yes. HEALTHCAP VII ADVISOR AB lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does HEALTHCAP VII ADVISOR AB write?
HEALTHCAP VII ADVISOR AB writes $1M–$5M checks.
Where does HEALTHCAP VII ADVISOR AB invest?
HEALTHCAP VII ADVISOR AB invests in Europe, Nordics and Global.